Public Company News

36Kr Holding Inc. Announces Changes to Board of Directors

BEIJING, March 6, 2024 /PRNewswire/ -- 36Kr Holdings Inc. ("36Kr" or the "Company" or "We") (NASDAQ: KRKR), a prominent brand and a pioneering platform dedicated to serving New Economy participants inChina, today announced that Mr. Hao Lan has resigned from the board of directors of the Company (...

2024-03-06 17:00 2889

Delta Honored Among Clarivate's Global Top 100 Innovators for Third Consecutive Year

TAIPEI, March 5, 2024 /PRNewswire/ -- Delta, a global leader in power management and provider of IoT-based smart green solutions, today announced its third consecutive inclusion in the Top 100 Global Innovators™ by Clarivate as recognition for its significant contribution to innovation and its st...

2024-03-06 11:51 1617

AACR 2024 | Ascentage Pharma to Present Three Preclinical Studies at 2024 American Association of Cancer Research Annual Meeting

ROCKVILLE, Md. and SUZHOU, China, March 5, 2024 /PRNewswire/ -- Ascentage Pharma (6855.HK), a global biopharmaceutical company engaged in developing novel therapies for cancer, age-related diseases, and chronic hepatitis B (CHB), announced today that the latest results from three preclinical stud...

2024-03-06 08:59 3108

ITANDI and RENOSY (Thailand) Collaborate and Begin Development of a Real Estate SaaS Business in Thailand

Aiming to strengthen the foundations of the property management DX business in theSoutheast Asia region TOKYO, March 5, 2024 /PRNewswire/ -- GA Technologies Co., Ltd. (Head office: Minato-ku,Tokyo; President, Representative Director and CEO: Ryo Higuchi , Stock Code: 3491; the "Company") hereby a...

2024-03-06 07:30 1612

Datasea Expects Approximately 1,128% Revenue Growth in 2024

BEIJING, March 5, 2024 /PRNewswire/ -- Datasea Inc. (NASDAQ: DTSS) ("Datasea" or the "Company"), aNevada corporation engaged in innovative business segments for Acoustics Intelligence and 5G-AI multimodal communication technology inChina and the US, issued guidance today for expecting a revenue o...

2024-03-05 23:45 3017

Addentax Group Corp. and Regina Miracle International (Holdings) Limited Entered into a Collaboration Agreement to Enhance Textile and Garment Industry Services

SHENZHEN, China, March 5, 2024 /PRNewswire/ -- Addentax Group Corp. ("Addentax" or the "Company") (Nasdaq: ATXG), an integrated service provider focusing on garment manufacturing, logistics services, property management, and subleasing, has announced that it has collaborated with Hong Kong Stock ...

2024-03-05 22:45 1631

Cheche Group Expands Partnership with Sinopec to Deliver Digital Insurance Solutions to Retail Network

BEIJING, March 5, 2024 /PRNewswire/ -- Cheche Group Inc. (NASDAQ: CCG) ("Cheche" or the "Company"),China's leading auto insurance technology platform, has expanded its partnership with Sinopec Easy Joy Sales Co., Ltd ("Sinopec Easy Joy"), a subsidiary of China Petroleum & Chemical Corporation ("S...

2024-03-05 22:00 3052

COSMAX BIO Introduces The World's First Quadruple-effect 'Caviar Extract' For Extensive Skin Improvement

- Contains ultra-premium ingredient 'Gold Caviar' - Applicate enzyme processing and supercritical extraction method[1] - Increased effective ingredients, free amino acid SEOUL, South Korea, March 5, 2024 /PRNewswire/ -- COSMAX BIO's dietary supplement, developed with caviar known as one of the 'wo...

2024-03-05 22:00 1332

CLPS Incorporation Reports Financial Results for the First Half of Fiscal Year 2024

HONG KONG, March 5, 2024 /PRNewswire/ -- CLPS Incorporation (the "Company" or "CLPS") (Nasdaq: CLPS), today announced its unaudited financial results for the six months endedDecember 31, 2023, or the first half of the Company's fiscal year 2024. During this period, CLPS navigated a challenging g...

2024-03-05 21:30 3278

WuXi Biologics Achieves Leadership Level in 2023 CDP Climate Change Assessment

SHANGHAI, March 5, 2024 /PRNewswire/ -- WuXi Biologics ("WuXi Bio") (2269.HK), a leading global Contract Research, Development and Manufacturing Organization (CRDMO), announced it has been recognized for outstanding performance in the 2023 Climate Change Assessment conducted by the global environ...

2024-03-05 21:00 1684

YS Biopharma Announces Board Changes and Strategic Leadership Appointments in Chinese Subsidiaries

GAITHERSBURG, Md., March 5, 2024 /PRNewswire/ -- YS Biopharma Co., Ltd. (Nasdaq: YS) ("YS Biopharma" or the "Company"), a global biopharmaceutical company dedicated to discovering, developing, manufacturing, and delivering new generations of vaccines and therapeutic biologics for infectious disea...

2024-03-05 21:00 2822

Snail Games Announces ARK Franchise Tops Charts at Steam's Dinos vs. Robots Fest

CULVER CITY, Calif., March 5, 2024 /PRNewswire/ -- Snail, Inc. (Nasdaq: SNAL) ("Snail Games" or "the Company"), a leading global independent developer and publisher of interactive digital entertainment, today announced the ARK franchise's achievement at Steam's Dinos vs. Robots Fest, held fromFeb...

2024-03-05 21:00 1242

Cango Inc. to Report Fourth Quarter and Full Year 2023 Financial Results on March 11, 2024 Eastern Time

SHANGHAI, March 5, 2024 /PRNewswire/ -- Cango Inc. (NYSE: CANG) ("Cango" or the "Company"), a leading automotive transaction service platform in China, today announced that it plans to release its fourth quarter and full year 2023 financial results after the market closes on Monday, March 11, 202...

2024-03-05 20:00 2464

NaaS Technology Inc. to Participate in Upcoming Investor Conferences in March 2024

BEIJING, March 5, 2024 /PRNewswire/ -- NaaS Technology Inc. (Nasdaq: NAAS) ("NaaS" or the "Company"), the first U.S. listed EV charging service company in China, today announced that management will participate in the following upcoming investor conferences in March: * 36th Annual ROTH Confere...

2024-03-05 19:00 2604

FinVolution Group to Report Fourth Quarter and Fiscal Year 2023 Financial Results on Monday, March 18, 2024

-Earnings Call Scheduled for 8:30 p.m. ET on March 18, 2024- SHANGHAI, March 5, 2024 /PRNewswire/ -- FinVolution Group ("FinVolution", or the "Company") (NYSE: FINV), a leading fintech platform, today announced that it will report its fourth quarter and fiscal year 2023 unaudited financial resul...

2024-03-05 19:00 2169

ZKH Group Limited to Announce Fourth Quarter and Fiscal Year 2023 Financial Results on Tuesday, March 19, 2024

SHANGHAI, March 5, 2024 /PRNewswire/ -- ZKH Group Limited ("ZKH" or the "Company") (NYSE: ZKH), a leading maintenance, repair and operations ("MRO") procurement service platform inChina, today announced that it will release its unaudited financial results for the fourth quarter and fiscal year en...

2024-03-05 18:00 2042

Viomi Technology Co., Ltd to Report Second Half and Full Year 2023 Financial Results on Monday, March 25, 2024

Earnings Call Scheduled for 8:00 A.M. ET on March 25, 2024 GUANGZHOU, China, March 5, 2024 /PRNewswire/ -- Viomi Technology Co., Ltd ("Viomi" or the "Company") (NASDAQ: VIOT), a leading IoT @ Home technology company inChina, today announced that it will report its unaudited financial results for...

2024-03-05 17:00 2115

Lucas GC Limited Announces Pricing of Upsized Initial Public Offering

NEW YORK, March 4, 2024 /PRNewswire/ -- Lucas GC Limited (the "Company" or "Lucas"), an artificial intelligence (AI) technology-driven online agent-centric human capital management service provider focused initially on targeting professionals based on Platform-as-a-Service, or PaaS, in the hum...

2024-03-05 10:38 2129

Japanese Company GA technologies Announces Jun Ernesto Okumura as its Executive Officer of the Chief Data Officer

TOKYO, March 4, 2024 /PRNewswire/ -- GA technologies Co.,Ltd. (Headquarters: Minato District,Tokyo; CEO:Ryo Higuchi; Securities code: 3491; Hereinafter as "the Company")announces the assumption ofJun Ernesto Okumura as the Executive Officer of the Chief Data Officer (CDO) of the Company starts on...

2024-03-05 09:00 1685

Formosa Pharmaceuticals and AimMax Therapeutics Receive FDA Approval for Clobetasol Propionate Ophthalmic Suspension 0.05%, for the Treatment of Post-Operative Inflammation and Pain Following Ocular Surgery

TAIPEI, March 4, 2024 /PRNewswire/ -- Taiwan-based Formosa Pharmaceuticals (6838.TWO) and AimMax Therapeutics (United States) announced today that the U.S. Food and Drug Administration (FDA) has approved clobetasol propionate ophthalmic suspension 0.05% (APP13007), for the treatment of post-opera...

2024-03-05 06:55 1583
1 ... 113114115116117118119 ... 773